Table 1 Analysis of phospo and non-phospo eIF-2α protein levels in osteosarcoma tissues
From: Regulation of interferon pathway in 2-methoxyestradiol-treated osteosarcoma cells
Tumor Tissue sample | PhosphoeIF-2α/.eIF-2α ratio (fold change*) | diagnosis | Age at resection | Tumor site |
|---|---|---|---|---|
1 | -1 | Fibroblastic osteosarcoma | 20 | Femur |
2 | -4 | Chondroblastic osteosarcoma | 18 | Pelvis |
3 | -13 | Chondroblastic osteosarcoma | 13 | Pelvis |
4 | -13 | Chondroblastic osteosarcoma | 39 | Sacrum |
5 | -42 | Osteogenic osteosarcoma | 21 | Sacrum |
6 | -20 | Chondroblastic osteosarcoma | 40 | Sacrum |
7 | -4 | Chondroblastic osteosarcoma | 54 | Scapula |
8 | -15 | Osteogenic oseosarcoma | 20 | Femur |
9 | -9 | Osteogenic osteosarcoma | 11 | Femur |
10 | -11 | Chondroblastic osteosarcoma | 13 | Scapula |
11 | -4 | Osteosarcoma, lung metastasis | 57 | Pelvis |
12 | 0 | Osteogenic osteosarcoma | 15 | Tibia |
13 | 0 | Fibroblastic osteosarcoma | 17 | Femur |
14 | +10 | Fibroblastic osteosarocma | 53 | Pelvis |
15 | +3 | Osteogenic osteosarcoma | 54 | Femur |